Literature DB >> 6155197

Primary liver cancers in Japan.

.   

Abstract

Statistical analyses have been made by the Liver Cancer Study Group of Japan of 4031 cases of primary liver cancers diagnosed at 155 institutes during the period of Jan. 1, 1968-Dec. 31, 1977, based on the questionnaire in the form of individual file. They comprised 2411 cases of hepatocellular carcinoma, 268 of cholangiocellular carcinoma, 58 of the mixed type, 69 of hepatoblastoma, 23 of others, and 1202 cases with only clinical diagnosis. The survey and analyses mostly based on the histology-proven cases included gross anatomical and histological features of tumors, grades of anaplasia and growth patterns of tumor cells, pathology of noncancerous liver portion, frequency of accompanying cirrhosis or fibrosis, distant metastases, past history, frequency of hepatitis in the past history, frequency of positive HBsAg and anti-HBs, familial clustering of positive HBsAg tests, age distribution, subjective symptoms, objective signs, serum alpha-fetoprotein, celiac angiography findings, number of operations performed, kinds of surgical approaches made, extents of hepatic resection, prognosis in terms of survival in relation to various surgical treatments, chemotherapeutic agents used and routes of administration, prognosis as related to the accompanying parenchymal liver disease, and overall survival.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155197     DOI: 10.1002/1097-0142(19800515)45:10<2663::aid-cncr2820451030>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  51 in total

1.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

2.  Budd Chiari Syndrome and Intrahepatic Cholangiocarcinoma, An Unusual Combination: Case Report and Review of the Literature.

Authors:  Anshuman Elhence; Shivanand Gamanagatti; Prasenjit Das
Journal:  Perm J       Date:  2020-11

3.  Induction of apoptosis in a human hepatocellular carcinoma cell line by a neutralizing antibody to transforming growth factor-alpha.

Authors:  S Seki; Y Sakai; T Kitada; N Kawakita; A Yanai; H Tsutsui; H Sakaguchi; T Kuroki; T Monna
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 4.  Geographic heterogeneity of hepatocellular carcinoma.

Authors:  K Okuda
Journal:  Gastroenterol Jpn       Date:  1990-12

5.  Relationship between general or specific immunoreactivity and prognosis in postoperative patients with hepatocellular carcinoma.

Authors:  H Yamasaki; E Okamoto; T Komatsu; Y Manabe; S Shinka
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Laparoscopic hepatic resection for hepatocellular carcinoma.

Authors:  M Hashizume; K Takenaka; K Yanaga; M Ohta; K Kajiyama; K Shirabe; H Itasaka; T Nishizaki; K Sugimachi
Journal:  Surg Endosc       Date:  1995-12       Impact factor: 4.584

7.  Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis.

Authors:  Y Kinami; S Takashima; I Miyazaki
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

8.  Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma.

Authors:  Wei-Xing Guo; Ju-Xian Sun; Yu-Qiang Cheng; Jie Shi; Nan Li; Jie Xue; Meng-Chao Wu; Yi Chen; Shu-Qun Cheng
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

9.  Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation.

Authors:  L Belli; F Romani; L S Belli; L De Carlis; G Rondinara; F Baticci; E Del Favero; E Minola; F Donato; V Mazzaferro
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

10.  Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.

Authors:  Yong-Sheng Xiao; Zhao-You Tang; Jia Fan; Jian Zhou; Zhi-Quan Wu; Qi-Man Sun; Qiong Xue; Yan Zhao; Yin-Kun Liu; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2004-04-08       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.